文章名稱引用次數

• Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis176
• Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial152
• Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper110
• Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study104
• Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial103
• The global burden of paediatric and neonatal sepsis: a systematic review71
• Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial70
• Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life64
• Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials62
• The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era60